Abstract
Introduction Following the USA, India ranks the second position in the world for COVID-19 cases with the highest number of daily confirmed cases since September 2020. The peak of COVID-19 cases is the most warranted feature for understanding the curvature of COVID-19 cases.
Aim This study aims to analyse the growth rates of the daily confirmed cases and to provide an expected count of the peak of daily confirmed cases.
Data We retrieved data from an Application Programming Interface portal https://www.covid19india.org/ which is open access and publicly available.
Methods Exponential model was applied to estimate the growth rates of daily confirmed cases. The estimated growth rates were used for calculating the doubling time. The Lotka-Euler method was applied to calculate the effective reproduction rate. SARIMA model was developed for the growth rates to predict daily confirmed cases.
Results Results show the best fit of the exponential model over the daily confirmed cases. The growth rates estimated from the exponential model shows an unsteady, modest decline. Doubling time shows a linear increase. The effective reproduction rate declined from 3.6 persons in the third week of March 2020 to 1.14 persons at the end of August 2020 and 1.12 persons in the mid-September 2020. The diagnosis of the developed SARIMA model confirmed no trends in the residuals, no outliers, and nearly constant variance. The forecast suggests the peak value of daily confirmed cases would waver around 105,000 counts in the third week of September 2020. The cumulative COVID-19 cases would account for approximately 105 lakhs at the end of December 2020.
Conclusion The exponential model unravels a shift and a modest decline in the growth of daily confirmed cases. The trends in R(t) show analogue with the trends in growth rates of daily confirmed cases. The study shows that the SARIMA model is suitable for projecting daily confirmed cases. The results shed light on the understanding of the trends and epidemiological stage of COVID-19 disease, in the cognisance of the peak.
Contribution This study based on moments of the distribution of the daily confirmed cases of COVID-19 disease unravels the uncertainty about the peak and curvature of COVID-19 disease.
Research Highlights
The exponential model is the best fit over daily confirmed COVID-19 cases.
The trends in growth rates of daily confirmed cases show a swift decline during the five-and-a-half months period since April 2020.
The effective reproduction rate in India declined from 3.6 persons in the third week of March 2020 to 1.14 persons at the end of August 2020 and 1.12 persons in the mid of September 2020.
The forecast reveals that the peak of daily confirmed cases wavers at approximately 105,000 cases since the third week of September 2020.
The R(t) value would be equal to one in the first week of December 2020.
The cumulative confirmed cases of COVID-19 in India would account to approximately 105 lakhs at the end of December 2020.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The Study is based on the secondary data which is publicly available so the study does not required Clinical Trials.
Funding Statement
The authors have not received any funding or benefits from industry or elsewhere to conduct this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
International Institute for Population Sciences (IIPS), Mumbai
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We retrieved data from an Application Programming Interface portal which is open access and publicly available.
